Farmasoytiske preparater og fremgangsmate for fremstilling derav
A novel extended release oral solid dosage formulation of metoprolol succinate is provided which includes an extended release polymer base retardant coating and a process of production thereof. In the present invention metoprolol succinate tablets comprising of strengths varying from 12.5 to 200mg a...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | nor |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A novel extended release oral solid dosage formulation of metoprolol succinate is provided which includes an extended release polymer base retardant coating and a process of production thereof. In the present invention metoprolol succinate tablets comprising of strengths varying from 12.5 to 200mg are prepared via a wet granulation method and the formulation for release of metoprolol for upto 24 hours is provided. |
---|